Tag: competitive

Posted on

AstraZeneca asthma drug hits goal, to enter competitive market – Reuters


Reuters

AstraZeneca asthma drug hits goal, to enter competitive market
Reuters
L) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller. Benralizumab, which is likely to …
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 6 news articles »

View full post on asthma – Google News

Posted on

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market … – MarketWatch

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
MarketWatch
oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic …

and more »

View full post on asthma – Google News

Posted on

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market … – PR Newswire (press release)

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
PR Newswire (press release)
oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic …

and more »

View full post on asthma – Google News